{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer's disease", "Quercetin", "bioavailability", "cholinesterase inhibition", "flavonoid.", "neuroprotection"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "33213346", "DateCompleted": {"Year": "2021", "Month": "12", "Day": "17"}, "DateRevised": {"Year": "2022", "Month": "10", "Day": "03"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.2174/1570159X18666201119153807"], "Journal": {"ISSN": "1875-6190", "JournalIssue": {"Volume": "19", "Issue": "12", "PubDate": {"Year": "2021"}}, "Title": "Current neuropharmacology", "ISOAbbreviation": "Curr Neuropharmacol"}, "ArticleTitle": "Cholinesterase Inhibitory Potential of Quercetin towards Alzheimer's Disease - A Promising Natural Molecule or Fashion of the Day? - A Narrowed Review.", "Pagination": {"StartPage": "2205", "EndPage": "2213", "MedlinePgn": "2205-2213"}, "Abstract": {"AbstractText": ["Natural substances are known to have strong protective effects against neurodegenerative diseases. Among them, phenolic compounds, especially flavonoids, come to the fore with their neuroprotective effects. Since quercetin, which is found in many medicinal plants and foods, is also taken through diet, its physiological effects on humans are imperative. Many studies have been published up to date on the neuroprotective properties of quercetin, a flavanol derivative. However, there is no review published so far summarizing the effect of quercetin on the cholinesterase (ChE) enzymes related to the cholinergic hypothesis, which is one of the pathological mechanisms of Alzheimer's Disease (AD). However, ChE inhibitors, regardless of natural or synthetic, play a vital role in the treatment of AD. Although the number of studies on the ChE inhibitory effect of quercetin is limited, it deserves to be discussed in a review article. With this sensitivity, the neuroprotective effect of quercetin against AD through ChE inhibition was scrutinized in the current review study. In addition, studies on the bioavailability of quercetin and its capacity to cross the blood-brain barrier and how this capacity and bioavailability can be increased were given. Generally, studies containing data published in recent years were obtained from search engines such as PubMed, Scopus, and Medline and included herein. Consequently, quercetin should not be considered as a fashionable natural compound and should be identified as a promising compound, especially with increased bioavailability, for the treatment of AD."], "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, 06330 Ankara, Turkey."}], "LastName": "Orhan", "ForeName": "Ilkay Erdogan", "Initials": "IE"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United Arab Emirates", "MedlineTA": "Curr Neuropharmacol", "NlmUniqueID": "101157239", "ISSNLinking": "1570-159X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cholinesterase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "9IKM0I5T1E", "NameOfSubstance": "Quercetin"}, {"RegistryNumber": "EC 3.1.1.8", "NameOfSubstance": "Cholinesterases"}], "MeshHeadingList": [{"QualifierName": ["drug therapy"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Cholinesterase Inhibitors"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Cholinesterases"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Quercetin"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Griffiths G., Trueman L., Crowther T., Thomas B., Smith B. Onions--a global benefit to health. Phytother. Res. 2002;16(7):603\u2013615. doi: 10.1002/ptr.1222.", "ArticleIdList": ["10.1002/ptr.1222", "12410539"]}, {"Citation": "Nishimuro H., Ohnishi H., Sato M., Ohnishi-Kameyama M., Matsunaga I., Naito S., Ippoushi K., Oike H., Nagata T., Akasaka H., Saitoh S., Shimamoto K., Kobori M. Estimated daily intake and seasonal food sources of quercetin in Japan. Nutrients. 2015;7(4):2345\u20132358. doi: 10.3390/nu7042345.", "ArticleIdList": ["10.3390/nu7042345", "PMC4425148", "25849945"]}, {"Citation": "Poler\u00e0 N., Badolato M., Perri F., Carullo G., Aiello F. Quercetin and its natural sources in wound healing management. Curr. Med. Chem. 2019;26(31):5825\u20135848. doi: 10.2174/0929867325666180713150626.", "ArticleIdList": ["10.2174/0929867325666180713150626", "30009700"]}, {"Citation": "Brito A.F., Ribeiro M., Abrantes A.M., Pires A.S., Teixo R.J., Tralh\u00e3o J.G., Botelho M.F. Querce-tin in cancer treatment, alone or in combination with conventional therapeutics? Curr. Med. Chem. 2015;22(26):3025\u20133039. doi: 10.2174/0929867322666150812145435.", "ArticleIdList": ["10.2174/0929867322666150812145435", "26264923"]}, {"Citation": "Costa L.G., Garrick J.M., Roqu\u00e8 P.J., Pellacani C. Mechanisms of neuroprotection by quercetin: counteracting oxidative stress and more. 2016.", "ArticleIdList": ["PMC4745323", "26904161"]}, {"Citation": "Barreca D., Bellocco E., D\u2019Onofrio G., Nabavi S.F., Daglia M., Rastrelli L., Nabavi S.M. Neuro-protective effects of quercetin: from chemistry to medicine. CNS Neurol. Disord. Drug Targets. 2016;15(8):964\u2013975. doi: 10.2174/1871527315666160813175406.", "ArticleIdList": ["10.2174/1871527315666160813175406", "27528470"]}, {"Citation": "Velmurugan B.K., Rathinasamy B., Lohanathan B.P., Thiyagarajan V., Weng C.F. Neuroprotective role of phytochemicals. Molecules. 2018;23(10):2485. doi: 10.3390/molecules23102485.", "ArticleIdList": ["10.3390/molecules23102485", "PMC6222499", "30262792"]}, {"Citation": "Amanzadeh E., Esmaeili A., Rahgozar S., Nourbakhshnia M. Application of quercetin in neurologi-cal disorders: from nutrition to nanomedicine. Rev. Neurosci. 2019;30(5):555\u2013572. doi: 10.1515/revneuro-2018-0080.", "ArticleIdList": ["10.1515/revneuro-2018-0080", "30753166"]}, {"Citation": "Li Y., Yao J., Han C., Yang J., Chaudhry M.T., Wang S., Liu H., Yin Y. Quercetin, inflammation and immunity. Nutrients. 2016;8(3):167. doi: 10.3390/nu8030167.", "ArticleIdList": ["10.3390/nu8030167", "PMC4808895", "26999194"]}, {"Citation": "Mlcek J., Jurikova T., Skrovankova S., Sochor J. Quercetin and its anti-allergic immune response. Molecules. 2016;21(5):623. doi: 10.3390/molecules21050623.", "ArticleIdList": ["10.3390/molecules21050623", "PMC6273625", "27187333"]}, {"Citation": "Serban M.C., Sahebkar A., Zanchetti A., Mikhailidis D.P., Howard G., Antal D., Andrica F., Ahmed A., Aronow W.S., Muntner P., Lip G.Y., Graham I., Wong N., Rysz J., Banach M. Li-pid and blood pressure meta\u2010analysis collaboration (LBPMC) group. Effects of quercetin on blood pressure: a systematic review and meta-analysis of randomized controlled trials. J. Am. Heart Assoc. 2016;5(7):e002713. doi: 10.1161/JAHA.115.002713.", "ArticleIdList": ["10.1161/JAHA.115.002713", "PMC5015358", "27405810"]}, {"Citation": "Chen S., Jiang H., Wu X., Fang J. Therapeutic effects of quercetin on inflammation, obesity, and type 2 diabetes. Mediators Inflamm. 2016;2016:9340637. doi: 10.1155/2016/9340637.", "ArticleIdList": ["10.1155/2016/9340637", "PMC5149671", "28003714"]}, {"Citation": "Eid H.M., Haddad P.S. The antidiabetic potential of quercetin: underlying mechanisms. Curr. Med. Chem. 2017;24(4):355\u2013364. doi: 10.2174/0929867323666160909153707.", "ArticleIdList": ["10.2174/0929867323666160909153707", "27633685"]}, {"Citation": "Zhao Y., Chen B., Shen J., Wan L., Zhu Y., Yi T., Xiao Z. The beneficial effects of quercetin, curcumin, and resveratrol in obesity. Oxid. Med. Cell. Longev. 2017;2017:1459497. doi: 10.1155/2017/1459497.", "ArticleIdList": ["10.1155/2017/1459497", "PMC5613708", "29138673"]}, {"Citation": "Rauf A., Imran M., Khan I.A., Ur-Rehman M., Gilani S.A., Mehmood Z., Mubarak M.S. Anti-cancer potential of quercetin: A comprehensive review. Phytother. Res. 2018;32(11):2109\u20132130. doi: 10.1002/ptr.6155.", "ArticleIdList": ["10.1002/ptr.6155", "30039547"]}, {"Citation": "Patel R.V., Mistry B.M., Shinde S.K., Syed R., Singh V., Shin H.S. Therapeutic potential of quercetin as a cardiovascular agent. Eur. J. Med. Chem. 2018;155:889\u2013904. doi: 10.1016/j.ejmech.2018.06.053.", "ArticleIdList": ["10.1016/j.ejmech.2018.06.053", "29966915"]}, {"Citation": "Babaei F., Mirzababaei M., Nassiri-Asl M. Quercetin in food: possible mechanisms of its effect on memory. J. Food Sci. 2018;83(9):2280\u20132287. doi: 10.1111/1750-3841.14317.", "ArticleIdList": ["10.1111/1750-3841.14317", "30103275"]}, {"Citation": "O\u017carowski, M.; Miko\u0142ajczak, P.&#321.; Kujawski, R.; Wielgus, K.; Klejewski, A.; Wolski, H.; Seremak-Mrozikiewicz, A. Pharmacological effect of quercetin in hypertension and its potential application in pregnancy-induced hypertension: review of in vitro, in vivo, and clinical studies. Evid. Based Complement. Alternat. Med. 2018;2018:7421489. doi: 10.1155/2018/7421489.", "ArticleIdList": ["10.1155/2018/7421489", "PMC6304490", "30622610"]}, {"Citation": "Shafabakhsh R., Asemi Z. Quercetin: a natural compound for ovarian cancer treatment. J. Ovarian Res. 2019;12(1):55. doi: 10.1186/s13048-019-0530-4.", "ArticleIdList": ["10.1186/s13048-019-0530-4", "PMC6570913", "31202269"]}, {"Citation": "Xu D., Hu M.J., Wang Y.Q., Cui Y.L. Antioxidant activities of quercetin and its complexes for medicinal application. Molecules. 2019;24(6):1123. doi: 10.3390/molecules24061123.", "ArticleIdList": ["10.3390/molecules24061123", "PMC6470739", "30901869"]}, {"Citation": "Kashyap D., Garg V.K., Tuli H.S., Yerer M.B., Sak K., Sharma A.K., Kumar M., Aggarwal V., Sandhu S.S. Fisetin and quercetin: promising flavonoids with chemopreventive potential. Biomolecules. 2019;9(5):174. doi: 10.3390/biom9050174.", "ArticleIdList": ["10.3390/biom9050174", "PMC6572624", "31064104"]}, {"Citation": "Memariani H., Memariani M., Ghasemian A. An overview on anti-biofilm properties of quercetin against bacterial pathogens. World J. Microbiol. Biotechnol. 2019;35(9):143. doi: 10.1007/s11274-019-2719-5.", "ArticleIdList": ["10.1007/s11274-019-2719-5", "31493142"]}, {"Citation": "Nakagawa T., Ohta K. Quercetin regulates the integrated stress response to improve memory. Int. J. Mol. Sci. 2019;20(11):2761. doi: 10.3390/ijms20112761.", "ArticleIdList": ["10.3390/ijms20112761", "PMC6600673", "31195662"]}, {"Citation": "Bule M., Abdurahman A., Nikfar S., Abdollahi M., Amini M. Antidiabetic effect of quercetin: A systematic review and meta-analysis of animal studies. Food Chem. Toxicol. 2019;125:494\u2013502. doi: 10.1016/j.fct.2019.01.037.", "ArticleIdList": ["10.1016/j.fct.2019.01.037", "30735748"]}, {"Citation": "Ossola B., K\u00e4\u00e4ri\u00e4inen T.M., M\u00e4nnist\u00f6 P.T. The multiple faces of quercetin in neuroprotection. Expert Opin. Drug Saf. 2009;8(4):397\u2013409. doi: 10.1517/14740330903026944.", "ArticleIdList": ["10.1517/14740330903026944", "19538101"]}, {"Citation": "Malik A., Khan F.A., Mumtaz A., Mehmood A., Azhar S., Atif M., Karim S., Altaf Y., Tariq I. Pharmacological applications of quercetin and its derivatives: a short review. Trop. J. Pharm. Res. 2014;13(9):1561\u20131566. doi: 10.4314/tjpr.v13i9.26.", "ArticleIdList": ["10.4314/tjpr.v13i9.26"]}, {"Citation": "Babaei F., Mirzababaei M., Nassiri-Asl M. Quercetin in food: possible mechanisms of \u0131ts effect on memory. J. Food Sci. 2018;83(9):2280\u20132287. doi: 10.1111/1750-3841.14317.", "ArticleIdList": ["10.1111/1750-3841.14317", "30103275"]}, {"Citation": "Zaplatic E., Bule M., Shah S.Z.A., Uddin M.S., Niaz K. Corrigendum to \u201cMolecular mechanisms underlying protective role of quercetin in attenuating Alzheimer\u2019s disease\u201d. Life Sci. 2019;231:116616. doi: 10.1016/j.lfs.2019.116616. [Life Sci. 221 (2019) 109-119].", "ArticleIdList": ["10.1016/j.lfs.2019.116616", "31326083"]}, {"Citation": "Khan H., Ullah H., Aschner M., Cheang W.S., Akkol E.K. Neuroprotective effects of quercetin in Alzheimer\u2019s disease. Biomolecules. 2019;10(1):59. doi: 10.3390/biom10010059.", "ArticleIdList": ["10.3390/biom10010059", "PMC7023116", "31905923"]}, {"Citation": "Dong F., Wang S., Wang Y., Yang X., Jiang J., Wu D., Qu X., Fan H., Yao R. Quercetin ame-liorates learning and memory via the Nrf2-ARE signaling pathway in d-galactose-induced neurotox-icity in mice. Biochem. Biophys. Res. Commun. 2017;491(3):636\u2013641. doi: 10.1016/j.bbrc.2017.07.151.", "ArticleIdList": ["10.1016/j.bbrc.2017.07.151", "28757412"]}, {"Citation": "Li Y., Tian Q., Li Z., Dang M., Lin Y., Hou X. Activation of Nrf2 signaling by sitagliptin and quercetin combination against \u03b2-amyloid induced Alzheimer\u2019s disease in rats. Drug Dev. Res. 2019;80(6):837\u2013845. doi: 10.1002/ddr.21567.", "ArticleIdList": ["10.1002/ddr.21567", "31301179"]}, {"Citation": "Jim\u00e9nez-Aliaga K., Bermejo-Besc\u00f3s P., Bened\u00ed J., Mart\u00edn-Arag\u00f3n S. Quercetin and rutin exhibit antiamyloidogenic and fibril-disaggregating effects in vitro and potent antioxidant activity in APPswe cells. Life Sci. 2011;89(25-26):939\u2013945. doi: 10.1016/j.lfs.2011.09.023.", "ArticleIdList": ["10.1016/j.lfs.2011.09.023", "22008478"]}, {"Citation": "Kanter M., Unsal C., Aktas C., Erboga M. Neuroprotective effect of quercetin against oxidative damage and neuronal apoptosis caused by cadmium in hippocampus. Toxicol. Ind. Health. 2016;32(3):541\u2013550. doi: 10.1177/0748233713504810.", "ArticleIdList": ["10.1177/0748233713504810", "24193051"]}, {"Citation": "Li Y.L., Guo H., Zhao Y.Q., Li A.F., Ren Y.Q., Zhang J.W. Quercetin protects neuronal cells from oxidative stress and cognitive degradation induced by amyloid \u03b2-peptide treatment. Mol. Med. Rep. 2017;16(2):1573\u20131577. doi: 10.3892/mmr.2017.6704.", "ArticleIdList": ["10.3892/mmr.2017.6704", "28586024"]}, {"Citation": "Rahvar M., Owji A.A., Mashayekhi F.J. Effect of quercetin on the brain-derived neurotrophic fac-tor gene expression in the rat brain. Bratisl. Lek Listy. 2018;119(1):28\u201331. doi: 10.4149/BLL_2018_006.", "ArticleIdList": ["10.4149/BLL_2018_006", "29405727"]}, {"Citation": "Chatterjee J., Langhnoja J., Pillai P.P., Mustak M.S. Neuroprotective effect of quercetin against radiation-induced endoplasmic reticulum stress in neurons. J. Biochem. Mol. Toxicol. 2019;33(2):e22242. doi: 10.1002/jbt.22242.", "ArticleIdList": ["10.1002/jbt.22242", "30368985"]}, {"Citation": "Abdalla F.H., Cardoso A.M., Pereira L.B., Schmatz R., Gon\u00e7alves J.F., Stefanello N., Fiorenza A.M., Gutierres J.M., Serres J.D., Zanini D., Pimentel V.C., Vieira J.M., Schetinger M.R., Morsch V.M., Mazzanti C.M. Neuroprotective effect of quercetin in ectoenzymes and acetylcho-linesterase activities in cerebral cortex synaptosomes of cadmium-exposed rats. Mol. Cell. Biochem. 2013;381(1-2):1\u20138. doi: 10.1007/s11010-013-1659-x.", "ArticleIdList": ["10.1007/s11010-013-1659-x", "23797318"]}, {"Citation": "de Oliveira T.S., Thomaz D.V., da Silva Neri H.F., Cerqueira L.B., Garcia L.F., Gil H.P.V., Pon-tarolo R., Campos F.R., Costa E.A., Dos Santos F.C.A., de Souza Gil E., Ghedini P.C. 2018.", "ArticleIdList": ["PMC6215548", "30420910"]}, {"Citation": "Spagnuolo C., Moccia S., Russo G.L. Anti-inflammatory effects of flavonoids in neurodegenerative disorders. Eur. J. Med. Chem. 2018;153:105\u2013115. doi: 10.1016/j.ejmech.2017.09.001.", "ArticleIdList": ["10.1016/j.ejmech.2017.09.001", "28923363"]}, {"Citation": "Zhang Z.J., Cheang L.C., Wang M.W., Lee S.M. Quercetin exerts a neuroprotective effect through inhibition of the iNOS/NO system and pro-inflammation gene expression in PC12 cells and in zebrafish. Int. J. Mol. Med. 2011;27(2):195\u2013203.", "ArticleIdList": ["21132259"]}, {"Citation": "Dajas F., Abin-Carriquiry J.A., Arredondo F., Blasina F., Echeverry C., Mart\u00ednez M., Rivera F., Vaamonde L. Quercetin in brain diseases: Potential and limits. Neurochem. Int. 2015;89:140\u2013148. doi: 10.1016/j.neuint.2015.07.002.", "ArticleIdList": ["10.1016/j.neuint.2015.07.002", "26160469"]}, {"Citation": "Park D.J., Shah F.A., Koh P.O. Quercetin attenuates neuronal cells damage in a middle cerebral ar-tery occlusion animal model. J. Vet. Med. Sci. 2018;80(4):676\u2013683. doi: 10.1292/jvms.17-0693.", "ArticleIdList": ["10.1292/jvms.17-0693", "PMC5938200", "29563391"]}, {"Citation": "Fan H.R., Du W.F., Zhu T., Wu Y.J., Liu Y.M., Wang Q., Wang Q., Gu X., Shan X., Deng S., Zhu T., Xu T.L., Ge W.H., Li W.G., Li F. Quercetin reduces cortical GABAergic transmission and alleviates MK-801-induced hyperactivity. EBioMedicine. 2018;34:201\u2013213. doi: 10.1016/j.ebiom.2018.07.031.", "ArticleIdList": ["10.1016/j.ebiom.2018.07.031", "PMC6116474", "30057312"]}, {"Citation": "Shimmyo Y., Kihara T., Akaike A., Niidome T., Sugimoto H. Flavonols and flavones as BACE-1 inhibitors: structure-activity relationship in cell-free, cell-based and in silico studies reveal novel pharmacophore features. Biochim. Biophys. Acta. 2008;1780(5):819\u2013825. doi: 10.1016/j.bbagen.2008.01.017.", "ArticleIdList": ["10.1016/j.bbagen.2008.01.017", "18295609"]}, {"Citation": "Saaby L., Rasmussen H.B., J\u00e4ger A.K. MAO-A inhibitory activity of quercetin from Calluna vul-garis (L.) Hull. J. Ethnopharmacol. 2009;121(1):178\u2013181. doi: 10.1016/j.jep.2008.10.012.", "ArticleIdList": ["10.1016/j.jep.2008.10.012", "19013512"]}, {"Citation": "Dhiman P., Malik N., Sobarzo-S\u00e1nchez E., Uriarte E., Khatkar A. Quercetin and related chrome-none derivatives as monoamine oxidase inhibitors: targeting neurological and mental disorders. Molecules. 2019;24(3):418. doi: 10.3390/molecules24030418.", "ArticleIdList": ["10.3390/molecules24030418", "PMC6385169", "30678358"]}, {"Citation": "Naushad M., Durairajan S.S.K., Bera A.K., Senapati S., Li M. Natural compounds with anti-BACE1 activity as promising therapeutic drugs for treating Alzheimer\u2019s disease. Planta Med. 2019;85(17):1316\u20131325. doi: 10.1055/a-1019-9819.", "ArticleIdList": ["10.1055/a-1019-9819", "31618777"]}, {"Citation": "Boyina H.K., Geethakhrishnan S.L., Panuganti S., Gangarapu K., Devarakonda K.P., Bakshi V., Guggilla S.R. In silico and in vivo studies on quercetin as potential anti-Parkinson agent. Adv. Exp. Med. Biol. 2020;1195:1\u201311. doi: 10.1007/978-3-030-32633-3_1.", "ArticleIdList": ["10.1007/978-3-030-32633-3_1", "32468451"]}, {"Citation": "Chen Q.X., Kubo I. Kinetics of mushroom tyrosinase inhibition by quercetin. J. Agric. Food Chem. 2002;50(14):4108\u20134112. doi: 10.1021/jf011378z.", "ArticleIdList": ["10.1021/jf011378z", "12083892"]}, {"Citation": "Fan M., Zhang G., Hu X., Xu X., Gong D. Quercetin as a tyrosinase inhibitor: Inhibitory activity, conformational change and mechanism. Food Res. Int. 2017;100(Pt 1):226\u2013233. doi: 10.1016/j.foodres.2017.07.010.", "ArticleIdList": ["10.1016/j.foodres.2017.07.010", "28873682"]}, {"Citation": "Du G., Zhao Z., Chen Y., Li Z., Tian Y., Liu Z., Liu B., Song J. Quercetin protects rat cortical neurons against traumatic brain injury. Mol. Med. Rep. 2018;17(6):7859\u20137865. doi: 10.3892/mmr.2018.8801.", "ArticleIdList": ["10.3892/mmr.2018.8801", "29620218"]}, {"Citation": "Kale A., Piskin \u00d6., Bas Y., Aydin B.G., Can M., Elmas \u00d6., B\u00fcy\u00fckuysal \u00c7. Neuroprotective ef-fects of Quercetin on radiation-induced brain injury in rats. J. Radiat. Res. (Tokyo) 2018;59(4):404\u2013410. doi: 10.1093/jrr/rry032.", "ArticleIdList": ["10.1093/jrr/rry032", "PMC6054235", "29688418"]}, {"Citation": "Wu M., Liu F., Guo Q. 2019."}, {"Citation": "Yang T., Kong B., Gu J.W., Kuang Y.Q., Cheng L., Yang W.T., Xia X., Shu H.F. Anti-apoptotic and anti-oxidative roles of quercetin after traumatic brain injury. Cell. Mol. Neurobiol. 2014;34(6):797\u2013804. doi: 10.1007/s10571-014-0070-9.", "ArticleIdList": ["10.1007/s10571-014-0070-9", "24846663"]}, {"Citation": "Du G., Zhao Z., Chen Y., Li Z., Tian Y., Liu Z., Liu B., Song J. Quercetin attenuates neuronal autophagy and apoptosis in rat traumatic brain injury model via activation of PI3K/Akt signaling pathway. Neurol. Res. 2016;38(11):1012\u20131019. doi: 10.1080/01616412.2016.1240393.", "ArticleIdList": ["10.1080/01616412.2016.1240393", "27690831"]}, {"Citation": "Qiu L., Luo Y., Chen X. Quercetin attenuates mitochondrial dysfunction and biogenesis via upregu-lated AMPK/SIRT1 signaling pathway in OA rats. Biomed. Pharmacother. 2018;103:1585\u20131591. doi: 10.1016/j.biopha.2018.05.003.", "ArticleIdList": ["10.1016/j.biopha.2018.05.003", "29864946"]}, {"Citation": "Houghton M.J., Kerimi A., Tumova S., Boyle J.P., Williamson G. Quercetin preserves redox status and stimulates mitochondrial function in metabolically-stressed HepG2 cells. Free Radic. Biol. Med. 2018;129:296\u2013309. doi: 10.1016/j.freeradbiomed.2018.09.037.", "ArticleIdList": ["10.1016/j.freeradbiomed.2018.09.037", "30266680"]}, {"Citation": "Teixeira J., Chavarria D., Borges F., Wojtczak L., Wieckowski M.R., Karkucinska-Wieckowska A., Oliveira P.J. Dietary Polyphenols and mitochondrial function: role in health and disease. Curr. Med. Chem. 2019;26(19):3376\u20133406. doi: 10.2174/0929867324666170529101810.", "ArticleIdList": ["10.2174/0929867324666170529101810", "28554320"]}, {"Citation": "Shirai M., Kawai Y., Yamanishi R., Kinoshita T., Chuman H., Terao J. Effect of a conjugated quercetin metabolite, quercetin 3-glucuronide, on lipid hydroperoxide-dependent formation of reac-tive oxygen species in differentiated PC-12 cells. Free Radic. Res. 2006;40(10):1047\u20131053. doi: 10.1080/10715760600794287.", "ArticleIdList": ["10.1080/10715760600794287", "17015249"]}, {"Citation": "Lee D.E., Shin B.J., Hur H.J., Kim J.H., Kim J., Kang N.J., Kim D.O., Lee C.Y., Lee K.W., Lee H.J. Quercetin, the active phenolic component in kiwifruit, prevents hydrogen peroxide-induced inhibition of gap-junction intercellular communication. Br. J. Nutr. 2010;104(2):164\u2013170. doi: 10.1017/S0007114510000346.", "ArticleIdList": ["10.1017/S0007114510000346", "20302682"]}, {"Citation": "Chen J., Han J., Wang J. Prevention of cytotoxicity of nickel by quercetin: the role of reactive oxy-gen species and histone acetylation. Toxicol. Ind. Health. 2013;29(4):360\u2013366. doi: 10.1177/0748233711433940.", "ArticleIdList": ["10.1177/0748233711433940", "22294440"]}, {"Citation": "Dudylina A.L., Ivanova M.V., Shumaev K.B., Ruuge E.K. Superoxide formation in cardiac mito-chondria and effect of phenolic antioxidants. Cell Biochem. Biophys. 2019;77(1):99\u2013107. doi: 10.1007/s12013-018-0857-2.", "ArticleIdList": ["10.1007/s12013-018-0857-2", "30218405"]}, {"Citation": "Lane R.M., Kivipelto M., Greig N.H. Acetylcholinesterase and its inhibition in Alzheimer disease. Clin. Neuropharmacol. 2004;27(3):141\u2013149. doi: 10.1097/00002826-200405000-00011.", "ArticleIdList": ["10.1097/00002826-200405000-00011", "15190239"]}, {"Citation": "Macdonald I.R., Rockwood K., Martin E., Darvesh S. Cholinesterase inhibition in Alzheimer\u2019s dis-ease: is specificity the answer? J. Alzheimers Dis. 2014;42(2):379\u2013384. doi: 10.3233/JAD-140219.", "ArticleIdList": ["10.3233/JAD-140219", "24898642"]}, {"Citation": "Wilkinson D.G., Francis P.T., Schwam E., Payne-Parrish J. Cholinesterase inhibitors used in the treatment of Alzheimer\u2019s disease: the relationship between pharmacological effects and clinical effi-cacy. Drugs Aging. 2004;21(7):453\u2013478. doi: 10.2165/00002512-200421070-00004.", "ArticleIdList": ["10.2165/00002512-200421070-00004", "15132713"]}, {"Citation": "Shanks M., Kivipelto M., Bullock R., Lane R. Cholinesterase inhibition: is there evidence for dis-ease-modifying effects? Curr. Med. Res. Opin. 2009;25(10):2439\u20132446. doi: 10.1185/03007990903209332.", "ArticleIdList": ["10.1185/03007990903209332", "19678754"]}, {"Citation": "Orhan G., Orhan I., Subutay-Oztekin N., Ak F., Sener B. Contemporary anticholinesterase phar-maceuticals of natural origin and their synthetic analogues for the treatment of Alzheimer\u2019s disease. Recent Patents CNS Drug Discov. 2009;4(1):43\u201351. doi: 10.2174/157488909787002582.", "ArticleIdList": ["10.2174/157488909787002582", "19149713"]}, {"Citation": "Orhan I.E. Implications of some selected flavonoids towards Alzheimer\u2019s disease with the emphasis on cholinesterase inhibition and their bioproduction by metabolic engineering. Curr. Pharm. Biotechnol. 2014;15(4):352\u2013361. doi: 10.2174/1389201015666140813123204.", "ArticleIdList": ["10.2174/1389201015666140813123204", "25312618"]}, {"Citation": "Saxena M., Dubey R. Target enzyme in Alzheimer\u2019s disease: acetylcholinesterase inhibitors. Curr. Top. Med. Chem. 2019;19(4):264\u2013275. doi: 10.2174/1568026619666190128125912.", "ArticleIdList": ["10.2174/1568026619666190128125912", "30706815"]}, {"Citation": "Ladner C.J., Lee J.M. Pharmacological drug treatment of Alzheimer disease: the cholinergic hypoth-esis revisited. J. Neuropathol. Exp. Neurol. 1998;57(8):719\u2013731. doi: 10.1097/00005072-199808000-00001.", "ArticleIdList": ["10.1097/00005072-199808000-00001", "9720487"]}, {"Citation": "Anand P., Singh B. A review on cholinesterase inhibitors for Alzheimer\u2019s disease. Arch. Pharm. Res. 2013;36(4):375\u2013399. doi: 10.1007/s12272-013-0036-3.", "ArticleIdList": ["10.1007/s12272-013-0036-3", "23435942"]}, {"Citation": "Sharma K. Cholinesterase inhibitors as Alzheimer\u2019s therapeutics. Mol. Med. Rep. 2019;20(2):1479\u20131487. [Review].", "ArticleIdList": ["PMC6625431", "31257471"]}, {"Citation": "Colombres M., Sagal J.P., Inestrosa N.C. An overview of the current and novel drugs for Alz-heimer\u2019s disease with particular reference to anti-cholinesterase compounds. Curr. Pharm. Des. 2004;10(25):3121\u20133130. doi: 10.2174/1381612043383359.", "ArticleIdList": ["10.2174/1381612043383359", "15544502"]}, {"Citation": "Mesulam M.M., Guillozet A., Shaw P., Levey A., Duysen E.G., Lockridge O. Acetylcholinester-ase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine. Neuroscience. 2002;110(4):627\u2013639. doi: 10.1016/S0306-4522(01)00613-3.", "ArticleIdList": ["10.1016/S0306-4522(01)00613-3", "11934471"]}, {"Citation": "Darvesh S. Butyrylcholinesterase as a diagnostic and therapeutic target for Alzheimer\u2019s disease. Curr. Alzheimer Res. 2016;13(10):1173\u20131177. doi: 10.2174/1567205013666160404120542.", "ArticleIdList": ["10.2174/1567205013666160404120542", "27040140"]}, {"Citation": "Szwajgier D. Anticholinesterase activity of selected phenolic acids and flavonoids - interaction test-ing in model solutions. Ann. Agric. Environ. Med. 2015;22(4):690\u2013694. doi: 10.5604/12321966.1185777.", "ArticleIdList": ["10.5604/12321966.1185777", "26706979"]}, {"Citation": "Lilienfeld S. Galantamine--a novel cholinergic drug with a unique dual mode of action for the treat-ment of patients with Alzheimer\u2019s disease. CNS Drug Rev. 2002;8(2):159\u2013176. doi: 10.1111/j.1527-3458.2002.tb00221.x.", "ArticleIdList": ["10.1111/j.1527-3458.2002.tb00221.x", "PMC6741688", "12177686"]}, {"Citation": "Marco L., do Carmo Carreiras M. Galanthamine, a natural product for the treatment of Alzheimer\u2019s disease. Recent Patents CNS Drug Discov. 2006;1(1):105\u2013111. doi: 10.2174/157488906775245246.", "ArticleIdList": ["10.2174/157488906775245246", "18221196"]}, {"Citation": "Georgieva L., Berkov S., Kondakova V., Bastida J., Viladomat F., Atanassov A., Codina C. Al-kaloid variability in Leucojum aestivum from wild populations. Z. Natforsch. C J. Biosci. 2007;62(9-10):627\u2013635. doi: 10.1515/znc-2007-9-1002.", "ArticleIdList": ["10.1515/znc-2007-9-1002", "18069233"]}, {"Citation": "Heinrich M. Galanthamine from Galanthus and other Amaryllidaceae--chemistry and biology based on traditional use. Alkaloids Chem. Biol. 2010;68:157\u2013165. doi: 10.1016/S1099-4831(10)06804-5.", "ArticleIdList": ["10.1016/S1099-4831(10)06804-5", "20334038"]}, {"Citation": "Demir A. Medical resource value appraisal for Leucojum aestivum in Turkey. Am. J. Alzheimers Dis. Other Demen. 2014;29(5):448\u2013451. doi: 10.1177/1533317514535334.", "ArticleIdList": ["10.1177/1533317514535334", "24833647"]}, {"Citation": "Pinho B.R., Ferreres F., Valent\u00e3o P., Andrade P.B. Nature as a source of metabolites with cholines-terase-inhibitory activity: an approach to Alzheimer\u2019s disease treatment. J. Pharm. Pharmacol. 2013;65(12):1681\u20131700. doi: 10.1111/jphp.12081.", "ArticleIdList": ["10.1111/jphp.12081", "24236980"]}, {"Citation": "Khan H. Marya; Amin, S.; Kamal, M.A.; Patel, S. Flavonoids as acetylcholinesterase inhibitors: Current therapeutic standing and future prospects. Biomed. Pharmacother. 2018;101:860\u2013870. doi: 10.1016/j.biopha.2018.03.007.", "ArticleIdList": ["10.1016/j.biopha.2018.03.007", "29635895"]}, {"Citation": "Uddin M.S., Kabir M.T., Niaz K., Jeandet P., Cl\u00e9ment C., Mathew B., Rauf A., Rengasamy K.R.R., Sobarzo-S\u00e1nchez E., Ashraf G.M., Aleya L. Molecular insight into the therapeutic promise of flavonoids against Alzheimer\u2019s disease. Molecules. 2020;25(6):1267. doi: 10.3390/molecules25061267.", "ArticleIdList": ["10.3390/molecules25061267", "PMC7143946", "32168835"]}, {"Citation": "Czernicka L., Ludwiczuk A., R\u00f3j E., Marzec Z., Jarzab A., Kukula-Koch W. Acetylcholinesterase inhibitors among Zingiber officinale terpenes-extraction conditions and thin layer chromatography-based bioautography studies. Molecules. 2020;25(7):1643. doi: 10.3390/molecules25071643.", "ArticleIdList": ["10.3390/molecules25071643", "PMC7181192", "32260053"]}, {"Citation": "Karakaya S., Koca M., Sytar O., Duman H. The natural phenolic compounds and their antioxidant and anticholinesterase potential of herb Leiotulus dasyanthus (K. Koch). Pimenov & Ostr. Nat. Prod. Res. 2020;34(9):1303\u20131305. doi: 10.1080/14786419.2018.1557176.", "ArticleIdList": ["10.1080/14786419.2018.1557176", "30657333"]}, {"Citation": "Ferreres F., Gil-Izquierdo A., Vinholes J., Silva S.T., Valent\u00e3o P., Andrade P.B. Bauhinia forfica-ta Link authenticity using flavonoids profile: relation with their biological properties. Food Chem. 2012;134(2):894\u2013904. doi: 10.1016/j.foodchem.2012.02.201.", "ArticleIdList": ["10.1016/j.foodchem.2012.02.201", "23107705"]}, {"Citation": "Cao J., Xia X., Dai X., Wang Q., Xiao J. Chemical composition and bioactivities of flavonoids-rich extract from Davallia cylindrica Ching. Environ. Toxicol. Pharmacol. 2014;37(2):571\u2013579. doi: 10.1016/j.etap.2014.01.011.", "ArticleIdList": ["10.1016/j.etap.2014.01.011", "24562055"]}, {"Citation": "Jabir N.R., Khan F.R., Tabrez S. Cholinesterase targeting by polyphenols: A therapeutic approach for the treatment of Alzheimer\u2019s disease. CNS Neurosci. Ther. 2018;24(9):753\u2013762. doi: 10.1111/cns.12971.", "ArticleIdList": ["10.1111/cns.12971", "PMC6489761", "29770579"]}, {"Citation": "Tung B.T., Thu D.K., Thu N.T.K., Hai N.T. 2017.", "ArticleIdList": ["29345437"]}, {"Citation": "Szwajger D., Borowiec K., Zapp J. Activity-guided isolation of cholinesterase inhibitors quercetin, rutin and kaempferol from Prunus persica fruit. Z. Naturforsch. C. 2020;75(3-4):87\u201396. doi: 10.1515/znc-2019-0079.", "ArticleIdList": ["10.1515/znc-2019-0079", "34432967"]}, {"Citation": "Achili I., Amrani A., Bensouici C., G\u00fcl F., Altun M., Demirtas I., Zama D., Benayache F., Be-nayache S. Chemical constituents, antioxidant, anticholinesterase and antiproliferative effects of Algerian Pistacia atlantica Desf. extracts. Recent Pat. Food Nutr. Agric. 2020;11(3):249\u2013256.", "ArticleIdList": ["32031082"]}, {"Citation": "Jung M., Park M. Acetylcholinesterase inhibition by flavonoids from Agrimonia pilosa. Molecules. 2007;12(9):2130\u20132139. doi: 10.3390/12092130.", "ArticleIdList": ["10.3390/12092130", "PMC6149129", "17962731"]}, {"Citation": "Katalini\u0107 M.; Rusak, G.; Doma\u0107inovi\u0107 Barovi\u0107 J.; Sinko, G.; Jeli\u0107 D.; Antolovi\u0107 R.; Kovarik, Z. Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase. Eur. J. Med. Chem. 2010;45(1):186\u2013192. doi: 10.1016/j.ejmech.2009.09.041.", "ArticleIdList": ["10.1016/j.ejmech.2009.09.041", "19879672"]}, {"Citation": "Orhan I., Kartal M., Tosun F., Sener B. Screening of various phenolic acids and flavonoid deriva-tives for their anticholinesterase potential. Z. Natforsch. C J. Biosci. 2007;62(11-12):829\u2013832. doi: 10.1515/znc-2007-11-1210.", "ArticleIdList": ["10.1515/znc-2007-11-1210", "18274286"]}, {"Citation": "Aderogba M.A., Ndhlala A.R., Rengasamy K.R.R., Van Staden J. Antimicrobial and selected in vitro enzyme inhibitory effects of leaf extracts, flavonols and indole alkaloids isolated from Croton menyharthii. Molecules. 2013;18(10):12633\u201312644. doi: 10.3390/molecules181012633.", "ArticleIdList": ["10.3390/molecules181012633", "PMC6270205", "24126380"]}, {"Citation": "Ryu H.W., Curtis-Long M.J., Jung S., Jeong I.Y., Kim D.S., Kang K.Y., Park K.H. Anticholines-terase potential of flavonols from paper mulberry (Broussonetia papyrifera) and their kinetic studies. Food Chem. 2012;132(3):1244\u20131250. doi: 10.1016/j.foodchem.2011.11.093.", "ArticleIdList": ["10.1016/j.foodchem.2011.11.093", "29243607"]}, {"Citation": "Sivori L.J., Casabe N.B., Zerba E.N., Wood E.J. Fenitrothion toxicity in Triatoma infestans syner-gized by quercetin or thymol blue. Pestic. Sci. 1999;55:18\u201326."}, {"Citation": "Zhang H.Y. Same causes, same cures. Biochem. Biophys. Res. Commun. 2006;351(3):578\u2013581. doi: 10.1016/j.bbrc.2006.10.086.", "ArticleIdList": ["10.1016/j.bbrc.2006.10.086", "17081501"]}, {"Citation": "Zhang H.Y., Yang D.P., Tang G.Y. Multipotent antioxidants: from screening to design. Drug Discov. Today. 2006;11(15-16):749\u2013754. doi: 10.1016/j.drudis.2006.06.007.", "ArticleIdList": ["10.1016/j.drudis.2006.06.007", "16846803"]}, {"Citation": "Sermboonpaisarn T., Sawasdee P. Potent and selective butyrylcholinesterase inhibitors from Ficus foveolata. Fitoterapia. 2012;83(4):780\u2013784. doi: 10.1016/j.fitote.2012.03.009.", "ArticleIdList": ["10.1016/j.fitote.2012.03.009", "22450264"]}, {"Citation": "Ding X., Ouyang M.A., Liu X., Wang R.Z. 2013."}, {"Citation": "Omar S.H., Scott C.J., Hamlin A.S., Obied H.K. Biophenols: Enzymes (\u03b2-secretase, Cholinester-ases, histone deacetylase and tyrosinase) inhibitors from olive (Olea europaea L.). Fitoterapia. 2018;128:118\u2013129. doi: 10.1016/j.fitote.2018.05.011.", "ArticleIdList": ["10.1016/j.fitote.2018.05.011", "29772299"]}, {"Citation": "Khan M.T., Orhan I., Senol F.S., Kartal M., Sener B., Dvorsk\u00e1 M., Smejkal K., Slapetov\u00e1 T. Cholinesterase inhibitory activities of some flavonoid derivatives and chosen xanthone and their mo-lecular docking studies. Chem. Biol. Interact. 2009;181(3):383\u2013389. doi: 10.1016/j.cbi.2009.06.024.", "ArticleIdList": ["10.1016/j.cbi.2009.06.024", "19596285"]}, {"Citation": "Kumar A., Mehta V., Raj U., Varadwaj P.K., Udayabanu M., Yennamalli R.M., Singh T.R. Computational and in vitro validation of natural molecules as potential acetylcholinesterase inhibitors and neuroprotective agents. Curr. Alzheimer Res. 2019;16(2):116\u2013127. doi: 10.2174/1567205016666181212155147.", "ArticleIdList": ["10.2174/1567205016666181212155147", "30543170"]}, {"Citation": "Ademosun A.O., Oboh G., Bello F., Ayeni P.O. Antioxidative properties and effect of quercetin and its glycosylated form (rutin) on acetylcholinesterase and butyrylcholinesterase activities. J. Evid. Based Complementary Altern. Med. 2016;21(4):NP11\u2013NP17. doi: 10.1177/2156587215610032.", "ArticleIdList": ["10.1177/2156587215610032", "26438716"]}, {"Citation": "Kaur S., Singla N., Dhawan D.K. Neuro-protective potential of quercetin during chlorpyrifos in-duced neurotoxicity in rats. Drug Chem. Toxicol. 2019;42(2):220\u2013230. doi: 10.1080/01480545.2019.1569022.", "ArticleIdList": ["10.1080/01480545.2019.1569022", "30747009"]}, {"Citation": "Abdel-Diam M.M., Samak D.H., El-Sayed Y.S., Aleya L., Alarifi S., Alkahtani S. Curcumin and quercetin synergistically attenuate subacute diazinon-induced inflammation and oxidative neurohe-patic damage, and acetylcholinesterase inhibition in albino rats. Environ. Sci. Pollut. Res. Int. 2019;26(4):3659\u20133665. doi: 10.1007/s11356-018-3907-9.", "ArticleIdList": ["10.1007/s11356-018-3907-9", "30535736"]}, {"Citation": "Adedara I.A., Ego V.C., Subair T.I., Oyediran O., Farombi E.O. Quercetin improves neurobehav-ioral performance through restoration of brain antioxidant status and acetylcholinesterase activity in manganese-treated rats. Neurochem. Res. 2017;42(4):1219\u20131229. doi: 10.1007/s11064-016-2162-z.", "ArticleIdList": ["10.1007/s11064-016-2162-z", "28144805"]}, {"Citation": "Youdim K.A., Shukitt-Hale B., Joseph J.A. Flavonoids and the brain: interactions at the blood-brain barrier and their physiological effects on the central nervous system. Free Radic. Biol. Med. 2004;37(11):1683\u20131693. doi: 10.1016/j.freeradbiomed.2004.08.002.", "ArticleIdList": ["10.1016/j.freeradbiomed.2004.08.002", "15528027"]}, {"Citation": "Rossi L., Mazzitelli S., Arciello M., Capo C.R., Rotilio G. Benefits from dietary polyphenols for brain aging and Alzheimer\u2019s disease. Neurochem. Res. 2008;33(12):2390\u20132400. doi: 10.1007/s11064-008-9696-7.", "ArticleIdList": ["10.1007/s11064-008-9696-7", "18415677"]}, {"Citation": "Liu L., Guo L., Zhao C., Wu X., Wang R., Liu C. 2015."}, {"Citation": "Luo Z., Morgan M.R., Day A.J. Transport of trans-tiliroside (kaempferol-3-\u03b2-D-(6\u201d-p-coumaroyl-glucopyranoside) and related flavonoids across Caco-2 cells, as a model of absorption and metabo-lism in the small intestine. Xenobiotica. 2015;45(8):722\u2013730. doi: 10.3109/00498254.2015.1007492.", "ArticleIdList": ["10.3109/00498254.2015.1007492", "25761590"]}, {"Citation": "Shi J., Zhu L., Li Y., Zheng H., Yu J., Lu L., Liu Z. In vitro study of UGT metabolism and per-meability of orientin and isoorientin, two active flavonoid C-glycosides. Drug Metab. Lett. 2016;10(2):101\u2013110. doi: 10.2174/1872312810666160219121217.", "ArticleIdList": ["10.2174/1872312810666160219121217", "26891873"]}, {"Citation": "Luo L.Y., Fan M.X., Zhao H.Y., Li M.X., Wu X., Gao W.Y. Pharmacokinetics and bioavailabil-ity of the isoflavones formononetin and ononin and their in vitro absorption in using chamber and caco-2 cell models. J. Agric. Food Chem. 2018;66(11):2917\u20132924. doi: 10.1021/acs.jafc.8b00035.", "ArticleIdList": ["10.1021/acs.jafc.8b00035", "29504397"]}, {"Citation": "Chen Y., Xue F., Xia G., Zhao Z., Chen C., Li Y., Zhang Y. Transepithelial transport mecha-nisms of 7,8-dihydroxyflavone, a small molecular TrkB receptor agonist, in human intestinal Caco-2 cells. Food Funct. 2019;10(8):5215\u20135227. doi: 10.1039/C9FO01007F.", "ArticleIdList": ["10.1039/C9FO01007F", "31384856"]}, {"Citation": "Fang Y., Cao W., Xia M., Pan S., Xu X. Study of structure and permeability relationship of fla-vonoids in Caco-2 cells. Nutrients. 2017;9(12):1301. doi: 10.3390/nu9121301.", "ArticleIdList": ["10.3390/nu9121301", "PMC5748751", "29186068"]}, {"Citation": "Kumar P., Sharma G., Kumar R., Singh B., Malik R., Katare O.P., Raza K. Promises of a bio-compatible nanocarrier in improved brain delivery of quercetin: Biochemical, pharmacokinetic and biodistribution evidences. Int. J. Pharm. 2016;515(1-2):307\u2013314. doi: 10.1016/j.ijpharm.2016.10.024.", "ArticleIdList": ["10.1016/j.ijpharm.2016.10.024", "27756627"]}, {"Citation": "Ren S.C., Suo Q.F., Du W.T., Pan H., Yang M.M., Wang R.H., Liu J. Quercetin permeability across blood-brain barrier and its effect on the viability of U251 cells. Sichuan Da Xue Xue Bao Yi Xue Ban. 2010;41(5):751\u2013754, 759.", "ArticleIdList": ["21302433"]}, {"Citation": "Yang Y., Bai L., Li X., Xiong J., Xu P., Guo C., Xue M. Transport of active flavonoids, based on cytotoxicity and lipophilicity: an evaluation using the blood-brain barrier cell and Caco-2 cell models. Toxicol. In Vitro. 2014;28(3):388\u2013396. doi: 10.1016/j.tiv.2013.12.002.", "ArticleIdList": ["10.1016/j.tiv.2013.12.002", "24362044"]}, {"Citation": "Nait Chabane M., Al Ahmad A., Peluso J., Muller C.D., Ubeaud G. Quercetin and naringenin transport across human intestinal Caco-2 cells. J. Pharm. Pharmacol. 2009;61(11):1473\u20131483. doi: 10.1211/jpp.61.11.0006.", "ArticleIdList": ["10.1211/jpp.61.11.0006", "19903372"]}, {"Citation": "Limtrakul P., Khantamat O., Pintha K. Inhibition of P-glycoprotein function and expression by kaempferol and quercetin. J. Chemother. 2005;17(1):86\u201395. doi: 10.1179/joc.2005.17.1.86.", "ArticleIdList": ["10.1179/joc.2005.17.1.86", "15828450"]}, {"Citation": "DiCenzo R., Frerichs V., Larppanichpoonphol P., Predko L., Chen A., Reichman R., Morris M. Effect of quercetin on the plasma and intracellular concentrations of saquinavir in healthy adults. Pharmacotherapy. 2006;26(9):1255\u20131261. doi: 10.1592/phco.26.9.1255.", "ArticleIdList": ["10.1592/phco.26.9.1255", "16945047"]}, {"Citation": "Sormunen H., Ruponen M., Laitinen R. The effect of co-amorphization of glibenclamide on its dissolution properties and permeability through an MDCKII-MDR1 cell layer. Int. J. Pharm. 2019;570:118653. doi: 10.1016/j.ijpharm.2019.118653.", "ArticleIdList": ["10.1016/j.ijpharm.2019.118653", "31472218"]}, {"Citation": "Ishisaka A., Ichikawa S., Sakakibara H., Piskula M.K., Nakamura T., Kato Y., Ito M., Miya-moto K., Tsuji A., Kawai Y., Terao J. Accumulation of orally administered quercetin in brain tis-sue and its antioxidative effects in rats. Free Radic. Biol. Med. 2011;51(7):1329\u20131336. doi: 10.1016/j.freeradbiomed.2011.06.017.", "ArticleIdList": ["10.1016/j.freeradbiomed.2011.06.017", "21741473"]}, {"Citation": "Sun D., Li N., Zhang W., Zhao Z., Mou Z., Huang D., Liu J., Wang W. Design of PLGA-functionalized quercetin nanoparticles for potential use in Alzheimer\u2019s disease. Colloids Surf. B Biointerfaces. 2016;148:116\u2013129. doi: 10.1016/j.colsurfb.2016.08.052.", "ArticleIdList": ["10.1016/j.colsurfb.2016.08.052", "27591943"]}, {"Citation": "Hashemian M., Ghasemi-Kasman M., Ghasemi S., Akbari A., Moalem-Banhangi M., Zare L., Ahmadian S.R. Fabrication and evaluation of novel quercetin-conjugated Fe3O4-\u03b2-cyclodextrin na-noparticles for potential use in epilepsy disorder. Int. J. Nanomedicine. 2019;14:6481\u20136495. doi: 10.2147/IJN.S218317.", "ArticleIdList": ["10.2147/IJN.S218317", "PMC6698168", "31496698"]}, {"Citation": "Moradi S.Z., Momtaz S., Bayrami Z., Farzaei M.H., Abdollahi M. Nanoformulations of herbal extracts in treatment of neurodegenerative disorders. Front. Bioeng. Biotechnol. 2020;8:238. doi: 10.3389/fbioe.2020.00238.", "ArticleIdList": ["10.3389/fbioe.2020.00238", "PMC7154137", "32318551"]}, {"Citation": "Di Martino P., Censi R., Gigliobianco M.R., Zerrillo L., Magnoni F., Agas D., Quaglia W., Lu-pidi G. Nano-medicine improving the bioavailability of small molecules for the prevention of neuro-degenerative diseases. Curr. Pharm. Des. 2017;23(13):1897\u20131908. doi: 10.2174/1381612822666161227154447.", "ArticleIdList": ["10.2174/1381612822666161227154447", "28025942"]}, {"Citation": "Rifaai R.A., Mokhemer S.A., Saber E.A., El-Aleem S.A.A., El-Tahawy N.F.G. Neuroprotective effect of quercetin nanoparticles: A possible prophylactic and therapeutic role in Alzheimer\u2019s disease. J. Chem. Neuroanat. 2020", "ArticleIdList": ["32464160"]}, {"Citation": "Pinheiro R.G.R., Granja A., Loureiro J.A., Pereira M.C., Pinheiro M., Neves A.R., Reis S. RVG29-Functionalized lipid nanoparticles for quercetin brain delivery and Alzheimer\u2019s disease. Pharm. Res. 2020;37(7):139. doi: 10.1007/s11095-020-02865-1.", "ArticleIdList": ["10.1007/s11095-020-02865-1", "32661727"]}, {"Citation": "Dhawan S., Kapil R., Singh B. Formulation development and systematic optimization of solid li-pid nanoparticles of quercetin for improved brain delivery. J. Pharm. Pharmacol. 2011;63(3):342\u2013351. doi: 10.1111/j.2042-7158.2010.01225.x.", "ArticleIdList": ["10.1111/j.2042-7158.2010.01225.x", "21749381"]}, {"Citation": "Rishitha N., Muthuraman A. Therapeutic evaluation of solid lipid nanoparticle of quercetin in pen-tylenetetrazole induced cognitive impairment of zebrafish. Life Sci. 2018;199:80\u201387. doi: 10.1016/j.lfs.2018.03.010.", "ArticleIdList": ["10.1016/j.lfs.2018.03.010", "29522770"]}, {"Citation": "Liu Y., Zhou H., Yin T., Gong Y., Yuan G., Chen L., Liu J. Quercetin-modified gold-palladium nanoparticles as a potential autophagy inducer for the treatment of Alzheimer\u2019s disease. J. Colloid Interface Sci. 2019;552:388\u2013400. doi: 10.1016/j.jcis.2019.05.066.", "ArticleIdList": ["10.1016/j.jcis.2019.05.066", "31151017"]}, {"Citation": "Ebrahimpour S., Esmaeili A., Beheshti S. Effect of quercetin-conjugated superparamagnetic iron oxide nanoparticles on diabetes-induced learning and memory impairment in rats. Int. J. Nanomedicine. 2018;13:6311\u20136324. doi: 10.2147/IJN.S177871.", "ArticleIdList": ["10.2147/IJN.S177871", "PMC6188001", "30349252"]}, {"Citation": "Enteshari Najafabadi R., Kazemipour N., Esmaeili A., Beheshti S., Nazifi S. Using superpara-magnetic iron oxide nanoparticles to enhance bioavailability of quercetin in the intact rat brain. BMC Pharmacol. Toxicol. 2018;19(1):59. doi: 10.1186/s40360-018-0249-7.", "ArticleIdList": ["10.1186/s40360-018-0249-7", "PMC6156978", "30253803"]}, {"Citation": "Kuo Y.C., Tsao C.W. Neuroprotection against apoptosis of SK-N-MC cells using RMP-7- and lac-toferrin-grafted liposomes carrying quercetin. Int. J. Nanomedicine. 2017;12:2857\u20132869. doi: 10.2147/IJN.S132472.", "ArticleIdList": ["10.2147/IJN.S132472", "PMC5391167", "28435263"]}]}], "History": [{"Year": "2020", "Month": "10", "Day": "11"}, {"Year": "2020", "Month": "10", "Day": "22"}, {"Year": "2020", "Month": "11", "Day": "15"}, {"Year": "2020", "Month": "11", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "11", "Day": "20", "Hour": "5", "Minute": "28"}, {"Year": "2022", "Month": "6", "Day": "13"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33213346", "PMC9185776", "10.2174/1570159X18666201119153807", "CN-EPUB-111670"]}}]}